Sign In to View Organizational & Contract Pricing
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
biological source
mouse
antibody form
purified from hybridoma cell culture
antibody product type
primary antibodies
clone
9B1-2G6, monoclonal
form
buffered aqueous solution
mol wt
antigen ~17 kDa
species reactivity
human
concentration
~1 mg/mL
technique(s)
immunoblotting: 2-4 μg/mL using histones isolated from human HeLa cells
immunofluorescence: 2-4 μg/mL using human HeLa cells
isotype
IgG1
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... H3C1(8350)
General description
Monoclonal Anti-unmodified-Histone H3 (Lys9 ) (mouse IgG1 isotype) is derived from the hybridoma 9B1-2G6 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a peptide. Histone H3 is a core component of histone octamer of nucleosome along with other histones H4, H2A and H2B. Histone H3 comprises lysine and arginine residues in the N-terminal region. Conserved lysine residues in the N-terminal tail domains of histone H3 comprise theLys4, Lys9 and Lys27, which are the preferred sites of methylation.
Immunogen
Peptide corresponding to amino acids surrounding Lys9 of human Histone H3, conjugated to KLH.
Application
Monoclonal Anti-unmodified-Histone H3 (Lys9) antibody produced in mouse has been used in:
- immunostaining
- immunoblotting
- immunofluorescence
Biochem/physiol Actions
Histones are subjected to extensive covalent modifications, including phosphorylation, methylation, acetylation and ubiquitination. These modifications are thought to play an important role in development and cancer. Histone H3 methylation at Lys9 is a modification intrinsically linked to epigenetic silencing and heterochromatin assembly. Histone methylation, as like acetylation, is a complex, dynamic process involving several processes, including transcriptional regulation, chromatin condensation, mitosis, and heterochromatin assembly. Moreover, lysine residues can be mono-, di-, and tri-methylated, adding further complexity to the regulation of chromatin structure.
Monoclonal Anti-unmodified-Histone H3 (Lys9 ) recognizes human unmodified-Histone H3 (Lys9 ) (nontested in other species). This antibody also binds to peptides containing mono-, and di-methyl-Lys4 and acetyl-Lys14 of Histone H3. It does not bind to peptides containing mono-, di-, and tri-methyl-Lys9 and acetylLys9 of Histone H3.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Preparation Note
For continuous use, store at 2-8°C for up to one month. For extended storage,freeze at -20oC in working aliquots. Repeated freezing and thawing,or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Modification of maternally defined H3K4me3 regulates the inviability of interspecific Xenopus hybrids.
Long, et al.
Science Advances, 9, eadd8343-eadd8343 (2023)
DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment
Varju I, et al.
Thrombosis and Haemostasis, 113(6), 1289-1298 (2015)
Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes
Saccani S and Natoli G
Genes & Development, 16(17), 2219-2224 (2002)
Cancer epigenetics: from mechanism to therapy
Dawson M A and Kouzarides T
Cell, 150(1), 12-27 (2012)
Chromatin modifications and their function
Kouzarides, Tony
Cell, 128(4), 693-705 (2007)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service